Physician profile
Vasanth Kumar Bethala
NPI 1548263999
$11,478.90
in general payments reported to CMS, 2019-2025
40 companies · $1,203 in 2025
The $1,203 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,718 · 2020: $857 · 2021: $619 · 2022: $1,453 · 2023: $1,457 · 2024: $1,172 · 2025: $1,203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,833.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,833.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $3,538.21 | 2019 | |
| Edwards Lifesciences Corporation | $690.67 | 2022-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Medtronic, INC. | $649.87 | 2021-2025 | Azure Xt Dr Mri Surescan, Linq II, Aquamantys(Tm) |
| Abiomed | $625.16 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $607.89 | 2019-2024 | Xarelto |
| Pfizer INC. | $533.80 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $465.89 | 2021-2025 | Camzyos, Eliquis |
| Boston Scientific Corporation | $432.01 | 2021-2025 | Synergy, Lux-Dx Insertable Cardiac Monitor, Latitude Communicator Power Supply |
| Siemens Medical Solutions USA, INC. | $429.88 | 2020 | |
| Irhythm Technologies, INC. | $338.92 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $323.23 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $313.66 | 2019-2025 | |
| Inspire Medical Systems, INC. | $251.35 | 2023-2025 | Inspire |
| Esperion Therapeutics, INC. | $232.88 | 2021-2023 | Nexletol |
| Abbott Laboratories | $226.20 | 2019-2025 | Cardiomems, Jot Dx |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $220.37 | 2019-2024 | |
| Baxter Healthcare | $175.73 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor |
| Merck Sharp & Dohme LLC | $164.29 | 2022-2025 | Verquvo |
| Amgen INC. | $160.04 | 2019-2025 | Repatha, Repatha |
| Kestra Medical Technology Services, INC. | $146.91 | 2022-2024 | Assure Wcd |
| Novo Nordisk INC | $136.42 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $117.86 | 2019-2025 | Jardiance |
| Ge Healthcare | $93.20 | 2020 | |
| Inari Medical, INC. | $89.45 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $77.66 | 2022-2025 | Farxiga |
| Kiniksa Pharmaceuticals, Ltd. | $77.32 | 2023 | Arcalyst |
| Stryker Corporation | $66.96 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $46.61 | 2021-2025 | |
| Actelion Pharmaceuticals US, INC. | $37.33 | 2019-2021 | |
| Zoll Medical Corporation | $36.31 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $25.46 | 2019 | |
| Biotronik INC. | $24.00 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $22.25 | 2023 | Inpefa |
| Itamar Medical INC | $20.12 | 2023 | Watchpatone |
| Kiniksa Pharmaceuticals International, Plc | $17.36 | 2024 | Arcalyst |
| Regeneron Healthcare Solutions, INC. | $16.95 | 2019 | |
| Sanofi Pasteur INC. | $15.25 | 2019 | |
| Kerecis Limited | $14.13 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Elutia, INC. | $14.06 | 2020 | |
| Bardy Diagnostics, INC. | $3.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vasanth Bethala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.